< Back to companies
Strominnate Therapeutics

Strominnate Therapeutics

Lund, Sweden

Strominnate Therapeutics targets challenging tumors like Glioblastoma multiforme (GBM), the most prevalent and aggressive brain tumor affecting adults. Current treatment consists of surgery, radiation therapy, and chemotherapy, but unfortunately, there exists no effective cure for GBM yet. Furthermore, GBM does not respond to immunotherapy either. The company develops innovative solutions for tumors like GBM that do not respond to treatments so that they become sensitive to immunotherapies. Strominnate Therapeutics´s approach is based on their unique know-how and protected use of a new immune cell with anti-tumor and immunomodulatory properties, stroma microglia.

Share
Shareable draft
Get Involved in Strominnate Therapeutics

Company Info

Founded
2021
Website
www.strominnate.com/

Categories

CancerTherapeuticsBiotechDrug Discovery/Development

Disease Areas

Technologies

TherapeuticsCell TherapyBiotechnologyImmunotherapy
Only accessible to MedStartr community members. Join now

What do you think of Strominnate Therapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Strominnate Therapeutics
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free